657 related articles for article (PubMed ID: 26538627)
21. Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: A nationwide population-based study.
Chien SH; Liu CJ; Hu YW; Hong YC; Teng CJ; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
Int J Cancer; 2015 Aug; 137(3):658-65. PubMed ID: 25630766
[TBL] [Abstract][Full Text] [Related]
22. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
23. Secondary Primary Malignancy Risk in Patients With Ovarian Cancer in Taiwan: A Nationwide Population-Based Study.
Hung YP; Liu CJ; Hu YW; Chen MH; Li CP; Yeh CM; Chiou TJ; Chen TJ; Yang MH; Chao Y
Medicine (Baltimore); 2015 Sep; 94(38):e1626. PubMed ID: 26402833
[TBL] [Abstract][Full Text] [Related]
24. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
25. Hazard ratios of second primary malignancy after radioiodine for differentiated thyroid carcinoma: a large-cohort retrospective study.
Wu W; Li S; Xu K; Meng Z
Endokrynol Pol; 2023; 74(3):260-270. PubMed ID: 37335064
[TBL] [Abstract][Full Text] [Related]
26. Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan.
Chen SC; Liu CJ; Hu YW; Yeh CM; Hu LY; Wang YP; Hung YP; Tzeng CH; Chiou TJ; Chen TJ; Teng CJ
Gastric Cancer; 2016 Apr; 19(2):490-497. PubMed ID: 25772342
[TBL] [Abstract][Full Text] [Related]
27. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
McCredie M; Macfarlane GJ; Bell J; Coates M
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
Bhatia S; Robison LL; Oberlin O; Greenberg M; Bunin G; Fossati-Bellani F; Meadows AT
N Engl J Med; 1996 Mar; 334(12):745-51. PubMed ID: 8592547
[TBL] [Abstract][Full Text] [Related]
29. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
30. Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study.
Piscopo L; Volpe F; Nappi C; Zampella E; Manganelli M; Matrisciano F; Totaro P; Pace L; Maurea S; Cuocolo A; Klain M
Curr Oncol; 2022 Dec; 30(1):37-44. PubMed ID: 36661652
[TBL] [Abstract][Full Text] [Related]
31. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
32. Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.
Hamilton SN; Tyldesley S; Hamm J; Jiang WN; Keyes M; Pickles T; Lapointe V; Kahnamelli A; McKenzie M; Miller S; Morris WJ
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):934-41. PubMed ID: 25240272
[TBL] [Abstract][Full Text] [Related]
33. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
34. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.
Lee KD; Chen SC; Chan CH; Lu CH; Chen CC; Lin JT; Chen MF; Huang SH; Yeh CM; Chen MC
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2647-55. PubMed ID: 18843006
[TBL] [Abstract][Full Text] [Related]
35. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
Hamilton SN; Tyldesley S; Li D; Olson R; McBride M
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):977-85. PubMed ID: 25832690
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
37. Is radioactive iodine- 131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
Souza MC; Momesso DP; Vaisman F; Vieira Neto L; Martins RA; Corbo R; Vaisman M
Arch Endocrinol Metab; 2016 Feb; 60(1):9-15. PubMed ID: 26222230
[TBL] [Abstract][Full Text] [Related]
38. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
39. Incidence of Second Primary Malignancies in Patients with Neuroendocrine Tumours.
Clift AK; Drymousis P; Al-Nahhas A; Wasan H; Martin J; Holm S; Frilling A
Neuroendocrinology; 2015; 102(1-2):26-32. PubMed ID: 25824138
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for second primary malignancies following thyroid cancer: a nationwide cohort study.
Kim M; Kim H; Park S; Joo J; Kim IJ; Kim BH
Eur J Endocrinol; 2022 Apr; 186(5):561-571. PubMed ID: 35286279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
